7RD4
Crystal structure of PfCSP peptide 21 with vaccine-elicited human anti-malaria antibody m43.149
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 22-ID |
Synchrotron site | APS |
Beamline | 22-ID |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2021-03-25 |
Detector | DECTRIS EIGER2 X 16M |
Wavelength(s) | 1 |
Spacegroup name | P 1 |
Unit cell lengths | 54.826, 55.099, 74.434 |
Unit cell angles | 77.62, 78.96, 69.72 |
Refinement procedure
Resolution | 45.210 - 1.750 |
R-factor | 0.1957 |
Rwork | 0.194 |
R-free | 0.23270 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 6b5l |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | PHENIX (1.19.1_4122) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 50.000 | 50.000 | 1.780 |
High resolution limit [Å] | 1.750 | 4.750 | 1.750 |
Rmerge | 0.062 | 0.032 | 0.230 |
Rmeas | 0.087 | 0.044 | 0.320 |
Rpim | 0.060 | 0.031 | 0.222 |
Total number of observations | 125698 | ||
Number of reflections | 67330 | 3339 | 3290 |
<I/σ(I)> | 10.9 | ||
Completeness [%] | 84.4 | 83.3 | 82.2 |
Redundancy | 1.9 | 1.9 | 1.8 |
CC(1/2) | 0.995 | 0.862 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 293 | 0.2 M sodium formate, 20% w/v PEG3350 |